Peak Financial Advisors’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
Other funds holding CTMX
KCM
Peak Financial Advisors's CTMX Position: Q3 2026 in Review
Peak Financial Advisors opened a new position in CytomX Therapeutics (CTMX) in Q3 2026: 462,061 shares worth $1.26M. The stake represents 0.54% of the portfolio and ranks #44 among its holdings.
193 funds tracked by Wall St. Rank hold CTMX as of Q3 2026.
- Peak Financial Advisors held 462,061 shares of CytomX Therapeutics worth $1.26M as of Q3 2026.
- CytomX Therapeutics was a new Peak Financial Advisors position in Q3 2026.
- CytomX Therapeutics made up 0.54% of Peak Financial Advisors's portfolio in Q3 2026, its #44 holding.
- 193 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q3 2026.
Based on Peak Financial Advisors's 13F filing for Q3 2026, filed 28 Oct 2026.